ALB and Cirrhosis: In general terms, 25% HSA is the therapeutic choice when fluid is restricted or in cases of oncotic deficiency,27 which is common in patients with cirrhosis who are prone to developing edema from infusions with a large intravenous volume, thereby making it the HSA formulation that should be used in most circumstances for patients with cirrhosis.